These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 25613012)

  • 1. Natural History of Parkinson's Disease in the Province of Segovia: Disability in a 20 Years Longitudinal Study.
    Duarte J; García Olmos LM; Mendoza A; Martínez Pueyo Á; Clavería LE
    Neurodegener Dis; 2015; 15(2):87-92. PubMed ID: 25613012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The natural history of Parkinson's disease in the province of Segovia: mortality in a longitudinal study (20-year follow-up).
    Duarte J; García Olmos LM; Mendoza A; Clavería LE
    Acta Neurol Scand; 2013 May; 127(5):295-300. PubMed ID: 22957805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression of motor impairment and disability in Parkinson disease: a population-based study.
    Alves G; Wentzel-Larsen T; Aarsland D; Larsen JP
    Neurology; 2005 Nov; 65(9):1436-41. PubMed ID: 16275832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocerebrosidase mutations influence the natural history of Parkinson's disease in a community-based incident cohort.
    Winder-Rhodes SE; Evans JR; Ban M; Mason SL; Williams-Gray CH; Foltynie T; Duran R; Mencacci NE; Sawcer SJ; Barker RA
    Brain; 2013 Feb; 136(Pt 2):392-9. PubMed ID: 23413260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What predicts mortality in Parkinson disease?: a prospective population-based long-term study.
    Forsaa EB; Larsen JP; Wentzel-Larsen T; Alves G
    Neurology; 2010 Oct; 75(14):1270-6. PubMed ID: 20921512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression of Parkinson's disease as evaluated by Hoehn and Yahr stage transition times.
    Zhao YJ; Wee HL; Chan YH; Seah SH; Au WL; Lau PN; Pica EC; Li SC; Luo N; Tan LC
    Mov Disord; 2010 Apr; 25(6):710-6. PubMed ID: 20213822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of non-motor symptoms on health-related and perceived quality of life in Parkinson's disease.
    Santos-García D; de la Fuente-Fernández R
    J Neurol Sci; 2013 Sep; 332(1-2):136-40. PubMed ID: 23890935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selegiline use is associated with a slower progression in early Parkinson's disease as evaluated by Hoehn and Yahr Stage transition times.
    Zhao YJ; Wee HL; Au WL; Seah SH; Luo N; Li SC; Tan LC
    Parkinsonism Relat Disord; 2011 Mar; 17(3):194-7. PubMed ID: 21159539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors for early mortality in Parkinson's disease.
    Oosterveld LP; Allen JC; Reinoso G; Seah SH; Tay KY; Au WL; Tan LC
    Parkinsonism Relat Disord; 2015 Mar; 21(3):226-30. PubMed ID: 25572499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Rating scale and functional prognosis of Parkinson's disease].
    Nakano I; Fujimoto K
    Nihon Rinsho; 2000 Oct; 58(10):2132-8. PubMed ID: 11068460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for freezing of gait in Parkinson's disease.
    Contreras A; Grandas F
    J Neurol Sci; 2012 Sep; 320(1-2):66-71. PubMed ID: 22795382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal metric properties of disability rating scales for Parkinson's disease.
    Martinez-Martin P; Prieto L; Forjaz MJ
    Value Health; 2006; 9(6):386-93. PubMed ID: 17076869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamics of change in self-reported disability among persons with Parkinson's disease after 2 years of follow-up.
    Gazibara T; Kisic-Tepavcevic D; Svetel M; Tomic A; Stankovic I; Kostic V; Pekmezovic T
    Neurol Sci; 2017 Aug; 38(8):1415-1421. PubMed ID: 28502059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinically important difference on the unified Parkinson's disease rating scale.
    Shulman LM; Gruber-Baldini AL; Anderson KE; Fishman PS; Reich SG; Weiner WJ
    Arch Neurol; 2010 Jan; 67(1):64-70. PubMed ID: 20065131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis of Parkinson's disease: time to stage III, IV, V, and to motor fluctuations.
    Sato K; Hatano T; Yamashiro K; Kagohashi M; Nishioka K; Izawa N; Mochizuki H; Hattori N; Mori H; Mizuno Y;
    Mov Disord; 2006 Sep; 21(9):1384-95. PubMed ID: 16763980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hippocampal volume and white matter disease in the prediction of dementia in Parkinson's disease.
    Kandiah N; Zainal NH; Narasimhalu K; Chander RJ; Ng A; Mak E; Au WL; Sitoh YY; Nadkarni N; Tan LC
    Parkinsonism Relat Disord; 2014 Nov; 20(11):1203-8. PubMed ID: 25258331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkinson's disease severity levels and MDS-Unified Parkinson's Disease Rating Scale.
    Martínez-Martín P; Rodríguez-Blázquez C; Mario Alvarez ; Arakaki T; Arillo VC; Chaná P; Fernández W; Garretto N; Martínez-Castrillo JC; Rodríguez-Violante M; Serrano-Dueñas M; Ballesteros D; Rojo-Abuin JM; Chaudhuri KR; Merello M
    Parkinsonism Relat Disord; 2015 Jan; 21(1):50-4. PubMed ID: 25466406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease progress and response to treatment as predictors of survival, disability, cognitive impairment and depression in Parkinson's disease.
    Vu TC; Nutt JG; Holford NH
    Br J Clin Pharmacol; 2012 Aug; 74(2):284-95. PubMed ID: 22300470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomised controlled cross-over trial of aerobic training versus Qigong in advanced Parkinson's disease.
    Burini D; Farabollini B; Iacucci S; Rimatori C; Riccardi G; Capecci M; Provinciali L; Ceravolo MG
    Eura Medicophys; 2006 Sep; 42(3):231-8. PubMed ID: 17039221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the clinical profile of Parkinson's disease between Spanish and Cameroonian cohorts.
    Cubo E; Doumbe J; Martinez-Martin P; Rodriguez-Blazquez C; Kuate C; Mariscal N; Lopez I; Noubissi G; Mapoure YN; Jon JL; Mbahe S; Tchaleu B; Catalan MJ;
    J Neurol Sci; 2014 Jan; 336(1-2):122-6. PubMed ID: 24183853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.